SCHEMBL27322913

SCHEMBL27322913

CC(C)(C)N(C=O)c1cnccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.33
▸ NAPRT Q6XQN6 1/20 0.31
▸ HCAR2 Q8TDS4 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ TP53 P04637 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ NFKB2 Q00653 1/20 0.31
▸ RELA Q04206 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ MC4R P32245 1/20 0.31
▸ ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6592179 0.76 POLB (0.47) POLBKDM4ENAPRTHCAR2HSP90AA1
SCHEMBL27529146 0.73 POLB (0.44) POLBKDM4ENAPRTHCAR2HSP90AA1
SCHEMBL28807709 0.73 POLB (0.43) POLBKDM4EHSP90AA1TP53SMN1; SMN2
SCHEMBL27862268 0.72 POLB (0.39) POLBKDM4ENAPRTHCAR2HSP90AA1
SCHEMBL27788485 0.72 POLB (0.39) POLBKDM4ENAPRTHCAR2HSP90AA1
SCHEMBL27972619 0.72 KCNA5 (0.41) LMNAGAAHTT
SCHEMBL28687108 0.68 POLB (0.40) POLBKDM4ENAPRTHCAR2HSP90AA1
SCHEMBL13367380 0.68 POLB (0.55) POLBKDM4ENAPRTHCAR2HSP90AA1
Ampyzine SCHEMBL30627403 0.68 — —
Ampyzine SCHEMBL160265 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1192014-C Process for preparing HIV protease inhibitors MERCK & CO INC (US) 2005-03-09 — — CN disclosed
CN-1100054-C Process for preparing HIV protease inhibitors from (2S) -4-picolyl-2-piperazine-tert-butylcarboxamide MERCK & CO INC (US) 2003-01-29 — — CN disclosed
CN-1083425-C Regiospecific process to make cis-1-amino-2-alkanol from epoxide MERCK & CO INC (US) 2002-04-24 — — CN disclosed
CN-1082964-C Chiral diphosphines MERCK & CO INC (US) 2002-04-17 — — CN disclosed
CN-1077881-C Regiospecific processes to make cis-1-amino-2-alkanol from diol or halohydrin MERCK & CO INC (US) 2002-01-16 — — CN disclosed
CN-1066728-C Process for producing epoxide MERCK & CO INC (US) 2001-06-06 — — CN disclosed
CN-1066723-C Intermediates for HIV protease inhibitors and process for preparing the same MERCK & CO INC (US) 2001-06-06 — — CN disclosed
CN-1252402-A Process for preparing HIV protease inhibitors MERCK & CO INC (US) 2000-05-10 — — CN disclosed
CN-1046727-C HIV protease inhibitors MERCK & CO INC (US) 1999-11-24 — — CN disclosed
CN-1046715-C Process for preparing HIV protease inhibitors MERCK & CO INC (US) 1999-11-24 — — CN disclosed
CN-1221422-A Novel chiral bisphosphines MERCK & CO INC (US) 1999-06-30 — — CN disclosed
CN-1183780-A Reductive alkylation process for the preparation of N- (2- (R) -hydroxy-1- (S) -2, 3-indanyl) -2- (R) -benzyl-4 (S) -hydroxy-5- (1- (4- (3-picolyl) -2(S) -N' - (tert-butylcarboxamido) piperazinyl) pentanamide (di-compound D or L-735,524) MERCK & CO INC (US) 1998-06-03 — — CN disclosed
CN-1147244-A Regiospecific processes to make cis-1-amino-2-alkanol from diol or halohydrin MERCK & CO INC (US) 1997-04-09 — — CN disclosed
CN-1147243-A Regiospecific process for the preparation of cis-1-amino-2-alkanols from epoxides MERCK & CO INC (US) 1997-04-09 — — CN disclosed
CN-1142827-A HIV protease inhibitors MERCK & CO INC (US) 1997-02-12 — — CN disclosed
CN-1130905-A Process for preparing HIV protease inhibitors MERCK & CO INC (US) 1996-09-11 — — CN disclosed
CN-1130380-A Process for preparing HIV protease inhibitors MERCK & CO INC (US) 1996-09-04 — — CN disclosed
Send feedback